Necrotizing Enterocolitis in Preterm Infants is Related to Enteral Feeding, But the Mechanisms Remain Uncertain and Have Changed Over Time
Tóm tắt
Although the pathophysiology of necrotizing enterocolitis (NEC) remains incompletely understood, recent evidence supports the important role of aberrant bacterial colonization and activated pro-inflammatory signaling in the high-risk premature infant (Neu and Walker, N Engl J Med 364:255–264, 2011). Nonetheless, most clinicians surmise that enteral feeding significantly contributes to the initiation of intestinal injury in NEC, and multiple studies have provided insight into the impact of feeding on intestinal health and homeostasis (Meinzen-Derr et al., J Perinatol 29:57–62, 2009). In this report, the impact of feeding on NEC will be reviewed, and it is suggested that enteral feedings can have a protective role in the disease, while conversely in other situations, enteral feedings might initiate changes contributing to this devastating condition. It is concluded that our understanding of enteral feeding and NEC has changed over time, and new insights continue to provide clues to the pathogenesis of this challenging condition.
Tài liệu tham khảo
• Neu J, Walker WA. Necrotizing enterocolitis. N Engl J Med. 2011;364:255–64. Authoritative recent review on NEC and its pathophysiology as related to the inflammatory process initiated in the highly immunoreactive intestine, Supports the ideas in this paper.
Meinzen-Derr J, Poindexter B, Wrage L, Morrow AL, Stoll B, Donovan EF. Role of human milk in extremely low birth weight infants’ risk of necrotizing enterocolitis or death. J Perinatol. 2009;29:57–62.
Wang Y, Hoenig JD, Malin KJ, Qamar S, Petrof EO, Sun J, et al. 16S rRNA gene-based analysis of fecal microbiota from preterm infants with and without necrotizing enterocolitis. ISME J. 2009;3:944–54.
Frost BL, Caplan MS. Necrotizing enterocolitis: pathophysiology, platelet-activating factor, and probiotics. Semin Pediatr Surg. 2013;22:88–93.
Mai V, Young CM, Ukhanova M, Wang X, Sun Y, Casella G, et al. Fecal microbiota in premature infants prior to necrotizing enterocolitis. PLoS One. 2011;6:e20647.
Gewolb IH, Schwalbe RS, Taciak VL, Harrison TS, Panigrahi P. Stool microflora in extremely low birthweight infants. Arch Dis Child Fetal Neonatal Ed. 1999;80:F167–73.
Hornef MW, Normark BH, Vandewalle A, Normark S. Intracellular recognition of lipopolysaccharide by toll-like receptor 4 in intestinal epithelial cells. J Exp Med. 2003;198:1225–35.
Jilling T, Simon D, Lu J, Meng FJ, Li D, Schy R, et al. The roles of bacteria and TLR4 in rat and murine models of necrotizing enterocolitis. J Immunol. 2006;177:3273–82.
• Lu J, Pierce M, Franklin A, Jilling T, Stafforini DM, Caplan M. Dual roles of endogenous platelet-activating factor acetylhydrolase in a murine model of necrotizing enterocolitis. Pediatr Res. 2010; 68:225–30. A key animal study for supporting the ideas in this paper.
Hunter CJ, De Plaen IG. Inflammatory signaling in NEC: role of NF-kappaB, cytokines and other inflammatory mediators. Pathophysiology. 2014;21:55–65.
Claud EC, Lu L, Anton PM, Savidge T, Walker WA, Cherayil BJ. Developmentally regulated IkappaB expression in intestinal epithelium and susceptibility to flagellin-induced inflammation. Proc Natl Acad Sci USA. 2004;101:7404–8.
Nowicki PT. Ischemia and necrotizing enterocolitis: where, when, and how. Semin Pediatr Surg. 2005;14:152–8.
Nowicki PT, Caniano DA, Hammond S, Giannone PJ, Besner GE, Reber KM, et al. Endothelial nitric oxide synthase in human intestine resected for necrotizing enterocolitis. J Pediatr. 2007;150:40–5.
Nowicki PT, Dunaway DJ, Nankervis CA, Giannone PJ, Reber KM, Hammond SB, et al. Endothelin-1 in human intestine resected for necrotizing enterocolitis. J Pediatr. 2005;146:805–10.
Szabo JS, Mayfield SR, Oh W, Stonestreet BS. Postprandial gastrointestinal blood flow and oxygen consumption: effects of hypoxemia in neonatal piglets. Pediatr Res. 1987;21:93–8.
Cassady G, Crouse DT, Kirklin JW, Strange MJ, Joiner CH, Godoy G, et al. A randomized, controlled trial of very early prophylactic ligation of the ductus arteriosus in babies who weighed 1,000 g or less at birth. N Engl J Med. 1989;320:1511–6.
Kameda H, Abei T, Nasrallah S, Iber FL. Functional and histological injury to intestinal mucosa produced by hypertonicity. Am J Physiol. 1968;214:1090–5.
Book LS, Herbst JJ, Atherton SO, Jung AL. Necrotizing enterocolitis in low-birth-weight infants fed an elemental formula. J Pediatr. 1975;87:602–5.
Radmacher PG, Adamkin MD, Lewis ST, Adamkin DH. Milk as a vehicle for oral medications: hidden osmoles. J Perinatol. 2012;32:227–9.
Powell GK. Enterocolitis in low-birth-weight infants associated with milk and soy protein intolerance. J Pediatr. 1976;88:840–4.
• Morita Y, Iwakura H, Ohtsuka H, Kohno Y, Shimojo N. Milk allergy in the neonatal intensive care unit: comparison between premature and full-term neonates. Asia Pacific allergy. 2013; 3:35–41. A key recent paper on non necrotizing enterocolitis in the NICU which has confused the diagnosis of NEC in the past.
Chuang SL, Hayes PJ, Ogundipe E, Haddad M, Macdonald TT, Fell JM. Cow’s milk protein-specific T-helper type I/II cytokine responses in infants with necrotizing enterocolitis. Pediatr Allergy Immunol. 2008;20(1):45–52.
Kuschel CA, Harding JE. Multicomponent fortified human milk for promoting growth in preterm infants. Cochrane Database Syst Rev. 2004;1:CD000343.
Sullivan S, Schanler RJ, Kim JH, Patel AL, Trawoger R, Kiechl-Kohlendorfer U, et al. An exclusively human milk-based diet is associated with a lower rate of necrotizing enterocolitis than a diet of human milk and bovine milk-based products. J Pediatr. 2010;156(562–7):e1.
Cristofalo EA, Schanler RJ, Blanco CL, Sullivan S, Trawoeger R, Kiechl-Kohlendorfer U, et al. Randomized trial of exclusive human milk versus preterm formula diets in extremely premature infants. J Pediatr. 2013;163(1592–5):e1.
Scheifele DW, Olsen E, Fussell S, Pendray M. Spontaneous endotoxinemia in premature infants: correlations with oral feeding and bowel dysfunction. J Pediatr Gastroenterol Nutr. 1985;4:67–74.
Beutler B. The toll-like receptors: analysis by forward genetic methods. Immunogenetics. 2005;57:385–92.
Amer MD, Hedlund E, Rochester J, Caplan MS. Platelet activating factor concentration in the stool of human newborns: effects of enteral feeding and neonatal necrotizing enterocolitis. Biol Neonate. 2004;85:159–66.
Caplan MS, Hedlund E, Adler L, Lickerman M, Hsueh W. The platelet-activating factor receptor antagonist WEB 2170 prevents neonatal necrotizing enterocolitis in rats. J Pediatr Gastroenterol Nutr. 1997;24:296–301.
Caplan MS, Lickerman M, Adler L, Dietsch GN, Yu A. The role of recombinant platelet-activating factor acetylhydrolase in a neonatal rat model of necrotizing enterocolitis. Pediatr Res. 1997;42:779–83.
• Soliman A, Michelsen KS, Karahashi H, Lu J, Meng FJ, Qu X, et al. Platelet-activating factor induces TLR4 expression in intestinal epithelial cells: implication for the pathogenesis of necrotizing enterocolitis. PLoS One. 2010; 5:e15044. Another key research paper in understanding the the proposed immunologic basis of NEC.
Aydin S, Ulusoy H, Usul H, Yulug E, Cobanoglu U, Aydin K, et al. Effects of early versus delayed nutrition on intestinal mucosal apoptosis and atrophy after traumatic brain injury. Surg Today. 2005;35:751–9.
Jilling T, Lu J, Jackson M, Caplan MS. Intestinal epithelial apoptosis initiates gross bowel necrosis in an experimental rat model of neonatal necrotizing enterocolitis. Pediatr Res. 2004;55:622–9.
Owens L, Burrin DG, Berseth CL. Minimal enteral feeding induces maturation of intestinal motor function but not mucosal growth in neonatal dogs. J Nutr. 2002;132:2717–22.
Konkel JE, Chen W. Balancing acts: the role of TGF-beta in the mucosal immune system. Trends Mol Med. 2011;17:668–76.
Maheshwari A, Kelly DR, Nicola T, Ambalavanan N, Jain SK, Murphy-Ullrich J, et al. TGF-beta2 suppresses macrophage cytokine production and mucosal inflammatory responses in the developing intestine. Gastroenterology. 2011;140:242–53.
Smythies LE, Sellers M, Clements RH, Mosteller-Barnum M, Meng G, Benjamin WH, et al. Human intestinal macrophages display profound inflammatory anergy despite avid phagocytic and bacteriocidal activity. J Clin Invest. 2005;115:66–75.